Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Apr 6, 2021 (6 years ago)

Triple SupremeZen Plus 3500

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.

Cause type: Chemical / undeclared

A chemical that should not be there - benzene, methanol, lead - or an undeclared prescription drug hidden in a supplement. The label gives no warning: you may be taking a toxic solvent, a heavy metal, or a drug such as sildenafil that interacts with your other medicines. All chemical / undeclared recalls.

What was recalled

Triple SupremeZen Plus 3500, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ

Recalling firm
Hyobin LLC
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0383-2021 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Hyobin LLC

All 2021 recalls

Other chemical / undeclared recalls from 2021

All chemical / undeclared recalls
Class II · Moderate risk

Secret Dry Spray

CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

Terminated Chemical / undeclared The Procter & Gamble Company D-0256-2024
Class II · Moderate risk

Secret

CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

Terminated Chemical / undeclared The Procter & Gamble Company D-0255-2024
Class II · Moderate risk

Secret

CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

Terminated Chemical / undeclared The Procter & Gamble Company D-0254-2024
Class II · Moderate risk

Secret

CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

Terminated Chemical / undeclared The Procter & Gamble Company NDC 37000-134-11 D-0253-2024